Category Archives: Cell Therapy

Latest Exercise & Fitness News MONDAY, Dec. 8, 2014 (HealthDay News) -- Some professional football players are seeking unproven stem cell therapies to speed their recovery from injuries. But experts are concerned that they may be unaware of the potential risks, a new report shows. Stem cell therapy has attracted the attention of elite athletes. A number of National Football League (NFL) players have highlighted their use of those therapies and their successful recoveries. Twelve NFL players are known to have received unapproved stem cell treatments since 2009. "The online data on NFL players and the clinics where they obtained treatment suggest that players may be unaware of the risks they are taking," report co-author Kirstin Matthews, a fellow in science and technology policy at Rice University's Baker Institute for Public Policy, said in a university news release. "Players who are official spokespersons for these clinics could influence others to view the therapies as safe and effective despite the lack of scientific research to support these claims," she added. Most of the players receive treatment in the United States, but several have gone to other countries for stem cell therapies that aren't available in the United States. "With the rise … Continue reading →

Sir Martin Evans - Investing with Cell Therapy Ltd Sir Martin Evans shares his enthusiasm regarding CTL's crowdfunding with professional investment platform - Crowdcube. By: Cell Therapy Ltd … Continue reading →

Contact Information Available for logged-in reporters only Newswise Philadelphia, Dec. 6, 2014 An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study. Ninety-two percent of the 39 children receiving bioengineered T cells had no evidence of cancer at one month after treatment, with this complete response persisting in some cases for more than two years. The personalized cell therapy reprograms a patients immune system and offers the potential of long-term success. As we continue to follow children in this study, we see exciting results for patients who have exhausted their other treatment options, said study leader Stephan A. Grupp, M.D., Ph.D., a pediatric oncologist at The Childrens Hospital of Philadelphia and a Professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania. Grupp described outcomes and follow-up results of this pilot clinical trial for pediatric patients with ALL in a press program today at the annual meeting of the American Society of Hematology (ASH) in San Francisco. Grupp, first author Shannon Maude, M.D., Ph.D., a pediatric oncologist at CHOP and Assistant Professor of Pediatrics at the Perelman School of … Continue reading →

Stem Cell Therapy | platelet rich fibrin glue stem cells http://www.arthritistreatmentcenter.com Glue as part of stem cell therapy next Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects Hal... By: Nathan Wei … Continue reading →

1st of the Month Freestyle Episode 2 Cell Therapy By: ArchangelVision … Continue reading →

PBR Staff Writer Published 02 December 2014 US-based Unum Therapeutics has started a Phase I trial designed to evaluate the feasibility, safety and potential efficacy of infusing the ATTCK20 combination therapy in patients with B-cell malignancies and persistent disease following standard therapy. Antibody-Targeted Tumor Cell Killing 20 (ATTCK20) is a combination of a patient's antibody-coupled T-cell receptor (ACTR) T-cells administered with rituximab, a monoclonal antibody targeting CD20. ACTR is a chimeric protein that combines components from receptors normally found on two different human immune cell types natural killer (NK) cells and T-cells in order to create new cancer cell killing activity. ATTCK occurs when T-cells expressing an ACTR engage a tumor-targeting antibody on the surface of a cancer cell. The first Phase I dose escalation trial for ATTCK20 is being conducted at National University Hospital (NUH) and Singapore General Hospital (SGH) in Singapore. Unum Therapeutics president and CEO Chuck Wilson said: "Despite recent advances in cancer treatments, there are still far too many individuals with B-cell malignancies who die from their disease. "With these unmet medical needs fueling our efforts, we are excited to see the start of clinical testing for ATTCK20." The company said that T-cells from patients in … Continue reading →

ARM Investor Day Alliance for Regenerative Medicine (ARM) Investor Day. By: Cell Therapy Catapult … Continue reading →

Stem Cell Therapy Project Daniel, John, Magno, Thahn, Victor, Vivian show the world just exactly what stem cells really are. By: John Peterman … Continue reading →

Stem Cell Therapy - BioLogic Anti-Aging Skin Cream http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care International Is Better Than Botox! By: Greg Smith … Continue reading →

Stem Cell Therapy Anti Aging Skin Cream Review and Exclusive Deal http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care System Free Trial. By: Greg Smith … Continue reading →